SDs of lasalocid with carriers of
PVP K30 (Sigma-Aldrich, St Louis, MO, USA),
PEG 4000 (BDH, London, UK), Pluronic
® F68 (Sigma-Aldrich), or Soluplus
® (BASF, Ludwigshafen, Germany) were prepared at different ratios (lasalocid:carrier 3:1, 5:1, or 9:1) by a conventional solvent evaporation method. Briefly, lasalocid and carriers were dissolved in a minimum volume of methanol, and the solvent was removed under vacuum in a Rotavapor at 50°C and 30 rpm for 5 hours, until all trace of methanol was removed. The solid products were then crushed out by a spatula and milled in a blender.
The DSC curves of pure lasalocid and each dispersion system were recorded on a TA Thermal Advantage™ DSC thermal analyzer (New Castle, DE, USA). Thermal behavior was studied by heating the samples (2–4 mg) in a sealed aluminum crucible, using an empty crucible as reference, over the temperature range 15–400°C at a rate of 10°C/minute.
FT-IR spectra were measured on a PerkinElmer
Spectrum 400 spectrometer equipped with an attenuated total reflectance (ATR, top-plate type) accessory (PerkinElmer, Waltham, MA, USA). A ~0.05 g sample was mounted onto crystal using air as a background reference before each scan. The samples were scanned over the range of 400–4,000 cm
−1 at a resolution of 2 cm
−1.
Wang W., Song Y., Petrovski K., Eats P., Trott D.J., Wong H.S., Page S.W., Perry J, & Garg S. (2015). Development of intramammary delivery systems containing lasalocid for the treatment of bovine mastitis: impact of solubility improvement on safety, efficacy, and milk distribution in dairy cattle. Drug Design, Development and Therapy, 9, 631-642.